Oligonucleotide CDMO Market to Hit $6.73 Billion by 2029 Amid Surge in Outsourced Gene-Based Drug Manufacturing

Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) –…
posteditor
posteditor
Articles: 21727

Other News